NOLAND HOSPITAL ANNISTON II — History
CCN 012011 | 3-year financial timeline | COVID resilience: 32/100
🛡️ Public data only — no PHI permitted on this instance.
$7M
Latest Revenue (FY2022)
-9.6%
Revenue CAGR (3yr)
9.6%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $9M | $9M | $7M | -14.2% | -9.6% |
| Operating Expenses | $8M | $7M | $7M | -7.0% | -7.8% |
| Operating Margin | 13.0% | 16.6% | 9.6% | -42.3% | -14.3% |
| Net Income | $1M | $1M | $1M | -50.5% | -22.6% |
| Licensed Beds | 38 | 38 | 38 | +0.0% | +0.0% |
| Total Patient Days | 6,571 | 6,025 | 5,165 | -14.3% | -11.3% |
| Medicare Day % | 67% | 52% | 58% | +11.5% | -6.8% |
| Medicaid Day % | nan% | nan% | nan% | +nan% | +nan% |
COVID Impact & Recovery
Resilience Score: 32/100 — Distressed — significant COVID damage
Revenue recovery from FY2020 to FY2022: -18.3% ($9M → $7M)
FY2020 captured the initial COVID shock. Slow recovery suggests structural challenges beyond COVID.
Trend Summary
Revenue▼ Declining
Operating Margin▼ Declining
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
-9.6%
This Hospital
+7.6%
State Avg
Latest Margin
9.6%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $7M | 7.8% |
| FY2024 (proj) | $6M | 6.1% |
| FY2025 (proj) | $5M | 4.4% |